MedPath

Stress Hyperglycemia and Acute Ischemic Stroke

Completed
Conditions
Stress Hyperglycemia
Interventions
Other: standard protocol for stroke patients
Registration Number
NCT04408768
Lead Sponsor
Ain Shams University
Brief Summary

Whereas diabetes mellitus is clearly a risk factor for the occurrence of stroke and for its poor prognosis, hyperglycemia per se is also linked to increased morbidity and mortality in stroke patients.Therefore, the objective of this work was to study the glycemic status of acute ischemic stroke patients and to assess its impact on stroke outcome.

Detailed Description

Using PASS program, setting alpha error at 5% and power of 80%, the total sample size was estimated to be 80 cases.

The NIHSS was used as a primary outcome; 40 cases were needed in each group. Secondary outcomes were hemorrhagic transformation, hospital stay duration, mechanical ventilation, need for vasopressors, and 30-days mortality.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Acute ischemic stroke within 24 hours of onset of symptoms
Read More
Exclusion Criteria
  • subdural hematoma
  • Transient ischemic attack
  • Subarachnoid hemorrhage
  • Hemorrhagic stroke
  • Major comorbidities Hyperglycemia on admission that was controlled (random blood sugar (RBS) < 150 mg/dl) within 24 hours with insulin therapy, diabetic
  • Ketoacidosis
  • RBS less than 70 mg/dl on admission
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
High RBSstandard protocol for stroke patientsHigh RBS on ICU admission and uncontrolled blood sugar during first 24 hours
Normal RBSstandard protocol for stroke patientsNormal RBS on ICU admission and controlled blood sugar within 24 hours
Primary Outcome Measures
NameTimeMethod
National Institutes of Health Stroke Scale (NIHSS)30 days

The NIHSS score categorized into: no stroke symptoms (0), mild stroke (1-4), moderate stroke (5-15), moderate to severe stroke (16-20), and sever (21-42)

Secondary Outcome Measures
NameTimeMethod
30-days mortality30 days

Hemorrhagic transformation, the length of hospital stay, need for mechanical ventilation and vasopressors and 30-days mortality

Trial Locations

Locations (1)

Hanaa El Gendy

🇪🇬

Cairo, Ain Shams University Specialized Hospital, Egypt

© Copyright 2025. All Rights Reserved by MedPath